124
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Effect of five nights of normobaric hypoxia on cardiovascular responses to acute isocapnic hypoxia in humans: relationship to ventilatory chemosensitivity

, , &
Pages 1523-1534 | Published online: 20 Feb 2007
 

Abstract

The aim of this study was to elucidate (1) the cardiovascular responses to acute isocapnic hypoxia stimuli following five nights of normobaric poikilocapnic hypoxia, and (2) whether the changes in the cardiovascular responses to hypoxia are correlated to the change in acute hypoxic ventilatory (AHVR) chemosensitivity. Twelve male subjects [26.6 ± 4.1 (SD) years] slept 8–9 h day−1 overnight for five consecutive days at a simulated altitude of 4300 m (FiO2 = ∼13.8%). Using the technique of dynamic end-tidal forcing, the AHVR was assessed twice, prior to and immediately after the hypoxic exposure. During each AHVR test, mean arterial blood pressure (MAP) and heart rate (HR) were measured continuously using finger photoplethysmography and an ECG monitor, respectively. Immediately following the exposure, AHVR and MAP sensitivities were increased by 1.80 ± 1.30 l min−1 %−1 (p < 0.01) and 0.69 ± 0.40 mmHg %−1 (p < 0.05), respectively, and there were significant correlations between the increases in the AHVR and MAP sensitivities (r = 0.67; p < 0.05). In summary, following five nights of normobaric hypoxia, there is an enhanced MAP response to hypoxic stimuli. The relationship between the enhanced AHVR and MAP sensitivity raises the possibility of a common pathway in the regulation of peripheral chemosensitivity and MAP responses during periods of isocapnic hypoxia.

Acknowledgments

This project was supported by the Alberta Heritage Foundation for Medical Research (AHFMR), the Heart and Stroke Foundation of Alberta, NWT and Nunavut, the Canadian Institutes of Health Research (CIHR) and the Olympic Oval Endowment Fund. P.N.A. is supported by a Focus-on-Stroke postdoctoral fellowship (Heart and Stroke Foundation of Canada, the Canadian Stroke Network, CIHR, and AstraZeneca Canada). K.I. is supported by a post-doctoral fellowship from the AHFMR. M.J.P. is a CIHR New Investigator and AHFMR Medical Scholar. We extend our gratitude to Professor P.A. Robbins for assistance in setting up the dynamic end-tidal forcing technique in Calgary.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.